RhumbLine Advisers’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-54,836
| Closed | -$85K | – | 4151 |
|
|
2025
Q1 | $85K | Sell |
54,836
-1,299
| -2% | -$2.01K | ﹤0.01% | 3446 |
|
|
2024
Q4 | $120K | Buy |
56,135
+7,290
| +15% | +$15.6K | ﹤0.01% | 3422 |
|
|
2024
Q3 | $212K | Buy |
48,845
+1,995
| +4% | +$8.68K | ﹤0.01% | 3209 |
|
|
2024
Q2 | $218K | Buy |
46,850
+46,401
| +10,334% | +$216K | ﹤0.01% | 3178 |
|
|
2024
Q1 | $2.28K | Hold |
449
| – | – | ﹤0.01% | 4079 |
|
|
2023
Q4 | $1.26K | Hold |
449
| – | – | ﹤0.01% | 4136 |
|
|
2023
Q3 | $1.29K | Hold |
449
| – | – | ﹤0.01% | 4160 |
|
|
2023
Q2 | $2.27K | Buy |
+449
| New | +$2.27K | ﹤0.01% | 4200 |
|
|
2022
Q2 | – | Sell |
-29,064
| Closed | -$81K | – | 3108 |
|
|
2022
Q1 | $81K | Sell |
29,064
-1,749
| -6% | -$4.87K | ﹤0.01% | 2926 |
|
|
2021
Q4 | $164K | Sell |
30,813
-580
| -2% | -$3.09K | ﹤0.01% | 2875 |
|
|
2021
Q3 | $266K | Buy |
31,393
+1,075
| +4% | +$9.11K | ﹤0.01% | 2811 |
|
|
2021
Q2 | $370K | Buy |
30,318
+12,012
| +66% | +$147K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $444K | Sell |
18,306
-1,105
| -6% | -$26.8K | ﹤0.01% | 2544 |
|
|
2020
Q4 | $622K | Buy |
19,411
+2,392
| +14% | +$76.6K | ﹤0.01% | 2344 |
|
|
2020
Q3 | $514K | Buy |
17,019
+1,879
| +12% | +$56.7K | ﹤0.01% | 2279 |
|
|
2020
Q2 | $638K | Buy |
15,140
+3,079
| +26% | +$130K | ﹤0.01% | 2234 |
|
|
2020
Q1 | $301K | Buy |
+12,061
| New | +$301K | ﹤0.01% | 2401 |
|